Wnt impacts growth and differentiation in ex vivo liver development

Experimental Cell Research

Volumn 292, Issue 1, 2004, Pages 157-169

  Hussain, Sunny Z ^a   Sneddon, Tamara ^a   Tan, Xinping ^a   Micsenyi, Amanda ^a   Michalopoulos, George K ^a   Monga, Satdarshan P S ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Biliary; Cancer; Development; Differentiation; Hepatocyte; HGF; Liver; Oncogenes; Organogenesis; Stem cell

Indexed keywords

ANTIBODY; CK19 ANTIBODY; INSULIN; PROTEIN HGF; SCATTER FACTOR; UNCLASSIFIED DRUG; WNT PROTEIN; WNT3A PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BILE DUCT; CELL DIFFERENTIATION; CELL GROWTH; CELL LINEAGE; CELL PROLIFERATION; CELL SPECIFICITY; CELL SURVIVAL; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; HISTOLOGY; LIVER; LIVER CELL; LIVER CELL CULTURE; LIVER DEVELOPMENT; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; STEM CELL;

STAPHYLOCOCCUS PHAGE 3A;

EID: 0346725843     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2003.08.020     Document Type: Article

References (65)

1. Peifer M., Polakis P. Wnt signaling in oncogenesis and embryogenesis - A look outside the nucleus. Science. 287:2000;1606-1609.
2. E. Pennisi, How a growth control path takes a wrong turn to cancer [news; comment] [published erratum appears in Science 1998 Sep 18; 281(5384):1809]. Science 281 (1998) 1438-9, 1441.
3. Kispert A., Vainio S., McMahon A.P. Wnt-4 is a mesenchymal signal for epithelial transformation of metanephric mesenchyme in the developing kidney. Development. 125:1998;4225-4234.
4. Cotter D., Kerwin R., al-Sarraji S., Brion J.P., Chadwich A., Lovestone S., Anderton B., Everall I. Abnormalities of Wnt signalling in schizophrenia - Evidence for neurodevelopmental abnormality. NeuroReport. 9:1998;1379-1383.
5. Cotter D., Honavar M., Lovestone S., Raymond L., Kerwin R., Anderton B., Everall I. Disturbance of Notch-1 and Wnt signalling proteins in neuroglial balloon cells and abnormal large neurons in focal cortical dysplasia in human cortex. Acta Neuropathol. (Berl.). 98:1999;465-472.
6. Cho E.A., Dressler G.R. TCF-4 binds beta-catenin and is expressed in distinct regions of the embryonic brain and limbs. Mech. Dev. 77:1998;9-18.
7. Grotewold L., Theil T., Ruther U. Expression pattern of Dkk-1 during mouse limb development. Mech. Dev. 89:1999;151-153.
8. Huelsken J., Vogel R., Erdmann B., Cotsarelis G., Birchmeier W. Beta-catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell. 105:2001;533-545.
9. Levin J.M., El Andalousi R.A., Dainat J., Reyne Y., Bacou F. SFRP2 expression in rabbit myogenic progenitor cells and in adult skeletal muscles. J. Muscle Res. Cell Motil. 22:2001;361-369.
10. Farr G.H. III, Ferkey D.M., Yost C., Pierce S.B., Weaver C., Kimelman D. Interaction among GSK-3, GBP, axin, and APC in Xenopus axis specification. J. Cell Biol. 148:2000;691-702.
11. Brault V., Moore R., Kutsch S., Ishibashi M., Rowitch D.H., McMahon A.P., Sommer L., Boussadia O., Kemler R. Inactivation of the beta-catenin gene by Wnt1-Cre-mediated deletion results in dramatic brain malformation and failure of craniofacial development. Development. 128:2001;1253-2364.
12. Haegel H., Larue L., Ohsugi M., Fedorov L., Herrenknecht K., Kemler R. Lack of beta-catenin affects mouse development at gastrulation. Development. 121:1995;3529-3537.
13. Arias A.M. Epithelial mesenchymal interactions in cancer and development. Cell. 105:2001;425-431.
14. Barker N., Morin P.J., Clevers H. The Yin-Yang of TCF/beta-catenin signaling. Adv. Cancer Res. 77:2000;1-24.
15. Kielman M.F., Rindapaa M., Gaspar C., van Poppel N., Breukel C., van Leeuwen S., Taketo M.M., Roberts S., Smits R., Fodde R. Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling. Nat. Genet. 32:2002;594-605.
16. Austin T.W., Solar G.P., Ziegler F.C., Liem L., Matthews W. A role for the Wnt gene family in hematopoiesis: expansion of multilineage progenitor cells. Blood. 89:1997;3624-3635.
17. Lako M., Lindsay S., Lincoln J., Cairns P.M., Armstrong L., Hole N. Characterisation of Wnt gene expression during the differentiation of murine embryonic stem cells in vitro: role of Wnt3 in enhancing haematopoietic differentiation. Mech. Dev. 103:2001;49-59.
18. Murdoch B., Chadwick K., Martin M., Shojaei F., Shah K.V., Gallacher L., Moon R.T., Bhatia M. Wnt-5A augments repopulating capacity and primitive hematopoietic development of human blood stem cells in vivo. Proc. Natl. Acad. Sci. U. S. A. 100:2003;3422-3427.
19. Young C.S., Kitamura M., Hardy S., Kitajewski J. Wnt-1 induces growth, cytosolic beta-catenin, and Tcf/Lef transcriptional activation in Rat-1 fibroblasts. Mol. Cell. Biol. 18:1998;2474-2485.
20. Papkoff J., Rubinfeld B., Schryver B., Polakis P. Wnt-1 regulates free pools of catenins and stabilizes APC-catenin complexes. Mol. Cell. Biol. 16:1996;2128-2134.
21. Cadoret A., Ovejero C., Terris B., Souil E., Levy L., Lamers W.H., Kitajewski J., Kahn A., Perret C. New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism. Oncogene. 21:2002;8293-8301.
22. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., Morin P.J., Vogelstein B., Kinzler K.W. Identification of c-MYC as a target of the APC pathway [see comments]. Science. 281:1998;1509-1512.
23. Mann B., Gelos M., Siedow A., Hanski M.L., Gratchev A., Ilyas M., Bodmer W.F., Moyer M.P., Riecken E.O., Buhr H.J., Hanski C. Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc. Natl. Acad. Sci. U. S. A. 96:1999;1603-1608.
24. Rubinfeld B., Albert I., Porfiri E., Fiol C., Munemitsu S., Polakis P. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly [see comments]. Science. 272:1996;1023-1026.
25. Shtutman M., Zhurinsky J., Simcha I., Albanese C., D'Amico M., Pestell R., Ben-Ze'ev A. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc. Natl. Acad. Sci. U. S. A. 96:1999;5522-5527.
26. Aberle H., Bauer A., Stappert J., Kispert A., Kemler R. Beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16:1997;3797-3804.
27. Uren A., Reichsman F., Anest V., Taylor W.G., Muraiso K., Bottaro D.P., Cumberledge S., Rubin J.S. Secreted frizzled-related protein-1 binds directly to Wingless and is a biphasic modulator of Wnt signaling. J. Biol. Chem. 275:2000;4374-4382.
28. de La Coste A., Romagnolo B., Billuart P., Renard C.A., Buendia M.A., Soubrane O., Fabre M., Chelly J., Beldjord C., Kahn A., Perret C. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl. Acad. Sci. U. S. A. 95:1998;8847-8851.
29. Huang H., Fujii H., Sankila A., Mahler-Araujo B.M., Matsuda M., Cathomas G., Ohgaki H. Beta-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection. Am. J. Pathol. 155:1999;1795-1801.
30. Kondo Y., Kanai Y., Sakamoto M., Genda T., Mizokami M., Ueda R., Hirohashi S. Beta-catenin accumulation and mutation of exon 3 of the beta-catenin gene in hepatocellular carcinoma. Jpn. J. Cancer Res. 90:1999;1301-1309.
31. Laurent-Puig P., Legoix P., Bluteau O., Belghiti J., Franco D., Binot F., Monges G., Thomas G., Bioulac-Sage P., Zucman-Rossi J. Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis. Gastroenterology. 120:2001;1763-1773.
32. Nhieu J.T., Renard C.A., Wei Y., Cherqui D., Zafrani E.S., Buendia M.A. Nuclear accumulation of mutated beta-catenin in hepatocellular carcinoma is associated with increased cell proliferation. Am. J. Pathol. 155:1999;703-710.
33. Satoh S., Daigo Y., Furukawa Y., Kato T., Miwa N., Nishiwaki T., Kawasoe T., Ishiguro H., Fujita M., Tokino T., Sasaki Y., Imaoka S., Murata M., Shimano T., Yamaoka Y., Nakamura Y. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat. Genet. 24:2000;245-250.
34. Monga S.P., Mars W.M., Pediaditakis P., Bell A., Mule K., Bowen W.C., Wang X., Zarnegar R., Michalopoulos G.K. Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes. Cancer Res. 62:2002;2064-2071.
35. Danilkovitch-Miagkova A., Miagkov A., Skeel A., Nakaigawa N., Zbar B., Leonard E.J. Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathway. Mol. Cell. Biol. 21:2001;5857-5868.
36. Jankowski J.A., Bruton R., Shepherd N., Sanders D.S. Cadherin and catenin biology represent a global mechanism for epithelial cancer progression. Mol. Pathol. 50:1997;289-290.
37. Kemler R. From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet. 9:1993;317-321.
38. Nakopoulou L., Gakiopoulou H., Keramopoulos A., Giannopoulou I., Athanassiadou P., Mavrommatis J., Davaris P.S. c-met tyrosine kinase receptor expression is associated with abnormal beta-catenin expression and favourable prognostic factors in invasive breast carcinoma. Histopathology. 36:2000;313-325.
39. Letamendia A., Labbe E., Attisano L. Transcriptional regulation by Smads: crosstalk between the TGF-beta and Wnt pathways. J. Bone Jt. Surg., Am. 83-A(Suppl. 1):2001;S31-S39.
40. Zorn A.M., Butler K., Gurdon J.B. Anterior endomesoderm specification in Xenopus by Wnt/beta-catenin and TGF-beta signalling pathways. Dev. Biol. 209:1999;282-297.
41. Weinstein M., Monga S.P., Liu Y., Brodie S.G., Tang Y., Li C., Mishra L., Deng C.X. Smad proteins and hepatocyte growth factor control parallel regulatory pathways that converge on beta1-integrin to promote normal liver development. Mol. Cell. Biol. 21:2001;5122-5131.
42. Taniguchi K., Roberts L.R., Aderca I.N., Dong X., Qian C., Murphy L.M., Nagorney D.M., Burgart L.J., Roche P.C., Smith D.I., Ross J.A., Liu W. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Oncogene. 21:2002;4863-4871.
43. Monga S.P., Pediaditakis P., Mule K., Stolz D.B., Michalopoulos G.K. Changes in WNT/beta-catenin pathway during regulated growth in rat liver regeneration. Hepatology. 33:2001;1098-1109.
44. Monga S.P., Tang Y., Candotti F., Rashid A., Wildner O., Mishra B., Iqbal S., Mishra L. Expansion of hepatic and hematopoietic stem cells utilizing mouse embryonic liver explants. Cell Transplant. 10:2001;81-89.
45. Mishra L., Cai T., Yu P., Monga S.P., Mishra B. Elf3 encodes a novel 200-kD beta-spectrin: role in liver development. Oncogene. 18:1999;353-364.
46. Mishra L., Tully R.E., Monga S.P., Yu P., Cai T., Makalowski W., Mezey E., Pavan W.J., Mishra B. Praja1, a novel gene encoding a RING-H2 motif in mouse development. Oncogene. 15:1997;2361-2368.
47. Monga S.P., Monga H.K., Tan X., Mule K., Pediaditakis P., Michalopoulos G.K. Beta-catenin antisense studies in embryonic liver cultures: role in proliferation, apoptosis, and lineage specification. Gastroenterology. 124:2003;202-216.
48. Cadoret A., Ovejero C., Saadi-Kheddouci S., Souil E., Fabre M., Romagnolo B., Kahn A., Perret C. Hepatomegaly in transgenic mice expressing an oncogenic form of beta-catenin. Cancer Res. 61:2001;3245-3249.
49. Le Douarin N., Houssaint E. Role of the mesoderm in the induction of the synthesis of glycogen during differentiation of the hepatic endoderm. C. R. Hebd. Seances Acad Sci., Ser. D. 264:1967;1872-1874.
50. Shibamoto S., Higano K., Takada R., Ito F., Takeichi M., Takada S. Cytoskeletal reorganization by soluble Wnt-3a protein signalling. Genes Cells. 3:1998;659-670.
51. Yamamoto H., Kishida S., Kishida M., Ikeda S., Takada S., Kikuchi A. Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3beta regulates its stability. J. Biol. Chem. 274:1999;10681-10684.
52. Kishida M., Koyama S., Kishida S., Matsubara K., Nakashima S., Higano K., Takada R., Takada S., Kikuchi A. Axin prevents Wnt-3a-induced accumulation of beta-catenin. Oncogene. 18:1999;979-985.
53. Morin P.J. Beta-catenin signaling and cancer. Bioessays. 21:1999;1021-1030.
54. Lustig B., Jerchow B., Sachs M., Weiler S., Pietsch T., Karsten U., van de Wetering M., Clevers H., Schlag P.M., Birchmeier W., Behrens J. Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors. Mol. Cell. Biol. 22:2002;1184-1193.
55. Murata M., Miyoshi Y., Ohsawa M., Shibata K., Ohta T., Imai Y., Nishikawa M., Iwao K., Tateishi H., Shimano T., Kobayashi T., Nakamura Y. Accumulation of beta-catenin in the cytoplasm and the nuclei during the early hepatic tumorigenesis. Hepatol. Res. 21:2001;126-135.
56. Tannapfel A., Wittekind C. Genes involved in hepatocellular carcinoma: deregulation in cell cycling and apoptosis. Virchows Arch. 440:2002;345-352.
57. Ikeya M., Lee S.M., Johnson J.E., McMahon A.P., Takada S. Wnt signalling required for expansion of neural crest and CNS progenitors. Nature. 389:1997;966-970.
58. Michalopoulos G.K., Bowen W.C., Mule K., Lopez-Talavera J.C., Mars W. Hepatocytes undergo phenotypic transformation to biliary epithelium in organoid cultures. Hepatology. 36:2002;278-283.
59. Prince M.I., Hudson M. Liver transplantation for chronic liver disease: advances and controversies in an era of organ shortages. Postgrad. Med. J. 78:2002;135-141.
60. Strom S.C., Chowdhury J.R., Fox I.J. Hepatocyte transplantation for the treatment of human disease. Semin. Liver Dis. 19:1999;39-48.
61. Sauer I.M., Obermeyer N., Kardassis D., Theruvath T., Gerlach J.C. Development of a hybrid liver support system. Ann. N.Y. Acad. Sci. 944:2001;308-319.
62. Patzer J.F. II Advances in bioartificial liver assist devices. Ann. N.Y. Acad. Sci. 944:2001;320-333.
63. Runge D., Michalopoulos G.K., Strom S.C., Runge D.M. Recent advances in human hepatocyte culture systems. Biochem. Biophys. Res. Commun. 274:2000;1-3.
64. Runge D., Runge D.M., Jager D., Lubecki K.A., Beer Stolz D., Karathanasis S., Kietzmann T., Strom S.C., Jungermann K., Fleig W.E., Michalopoulos G.K. Serum-free, long-term cultures of human hepatocytes: maintenance of cell morphology, transcription factors, and liver-specific functions. Biochem. Biophys. Res. Commun. 269:2000;46-53.
65. Katoh M. Expression and regulation of WNT1 in human cancer: up-regulation of WNT1 by beta-estradiol in MCF-7 cells. Int. J. Oncol. 22:2003;209-212.